Oveporexton News

19 Aug 20267:15 am

Pharmaceuticals19 Aug 2026 · 7:15 am7:15 am

FDA Approves Orzeyful, First Drug to Treat a Cause of Narcolepsy Type 1

The U.S. Food and Drug Administration (FDA) has approved Orzeyful (oveporexton), the first drug to treat a cause of narcolepsy by targeting the orexin pathway.

Oveporexton News

#Oveporexton

FDA Approves Orzeyful, First Drug to Treat a Cause of Narcolepsy Type 1

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs